Cutia Therapeutics Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
-470.00
-2,169.00
-646.00
-385.00
-224.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-110.00
-5.00
-33.00
-41.00
-5.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-474.00
-391.00
-267.00
-190.00
-194.00
Cash Flow from Investing Activities
328.00
-256.00
529.00
-496.00
-945.00
Cash Flow from Financing Activities
49.00
652.00
-11.00
579.00
1,495.00
Net Cash Inflow / Outflow
-94.00
8.00
305.00
-116.00
299.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
4.00
54.00
-8.00
-56.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cutia Therapeutics
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-470.348229340672
-442.096608676535
-28.00
-6.39%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-110.381576733844
95.438803736449
-205.00
-215.66%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-474.082296254257
-242.252470026126
-232.00
-95.70%
Cash Flow from Investing Activities
328.458023519808
-115.127224492486
443.00
385.30%
Cash Flow from Financing Activities
49.0546235302686
329.126989630633
-280.00
-85.10%
Net Cash Inflow / Outflow
-94.8153750270089
-26.8117714012911
-68.00
-253.63%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.7542741771721
1.44093348668833
0.00
21.75%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -20.97% vs -46.70% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-474.08
-391.90
-20.97%






